Posts tagged ‘Pharma Consultant’
February 8th, 2011
While at Quintiles, Pieter Droppert was a lead CRA and European project manager for risedronate clinical trials, and he has since maintained an interest in osteoporosis new product development.
On the Biotech Strategy Blog, he discusses a recent review published in Nature Reviews Drug Discovery on the emerging treatments in development for osteoporosis. He comments on some of the barriers to market entry that companies will increasingly face such as pressure not to do placebo-controlled trials with high fracture-risk subjects.
For further commentary and insight on the osteoporosis market, read the full post on Biotech Strategy Blog.
February 7th, 2011
All of us in the biotechnology or pharmaceutical industries with an interest in technology and how it can be leveraged to bring new drugs to market, received notice last Friday that the iPad is likely to have an impact on our industry.
The FDA announced their first approval of an app that allows physicians to view medical images on their iPhone and iPads, and use it to make a diagnosis.
If you own an iPad or aspire to own one, you can read more about this exciting new development on the Biotech Strategy Blog.
January 18th, 2011
Published by Sally Church on Pharma Strategy Blog